Mavria, Georgia <br/><br/>
In vivo efficacy of HSV-TK transcriptionally targeted to the tumour vasculature is augmented by combination with cytotoxic chemotherapy.  [electronic resource] 

 -  The journal of gene medicine  Mar 2005 
 - 263-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-498X 
<br/><br/><label>Standard No.: </label>10.1002/jgm.662  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Aorta--cytology<br/>Camptothecin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Drug Therapy, Combination<br/>Endothelial Cells--cytology<br/>Genes, Reporter<br/>Genetic Therapy--methods<br/>Genetic Vectors--genetics<br/>Humans<br/>Irinotecan<br/>Neoplasms--blood supply<br/>Retroviridae--genetics<br/>Simplexvirus--enzymology<br/>Survival Rate<br/>Swine<br/>Thymidine Kinase--genetics<br/>Transcription, Genetic<br/>Treatment Outcome